The program aims to provide an overview of genomic medicine and pharmacogenetics, review specialties where advancements in pharmacogenetics can improve the quality of care, and offer perspective from leading experts in how pharmacogenetics can transform clinical practice. Despite patient and clinician interest in genomic medicine, education is often the limiting factor to clinical application. The program will include general concepts necessary for foundational knowledge in genomic medicine. Attendees will be exposed to a variety of use cases for pharmacogenetics (e.g., pain management, psychiatry, cardiology) and molecular tumor profiling in oncology. Case-based discussions will allow practitioners and healthcare professionals to hear and discuss real-world experiences in using pharmacogenetics in the daily practice of medicine.

Target Audience:

This conference is intended for primary care providers, family practitioners, oncologists, psychiatrists, cardiologists, physician assistants, nurse practitioners, pharmacists and all other members of the healthcare team interested in pharmacogenomics.

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC)and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 9 Interprofessional Continuing Education (IPCE) credits for learning and change.